nodes	percent_of_prediction	percent_of_DWPC	metapath
Methimazole—CYP2B6—Thiotepa—sarcoma	0.242	0.27	CbGbCtD
Methimazole—CYP2E1—Dacarbazine—sarcoma	0.136	0.152	CbGbCtD
Methimazole—CYP2E1—Mitoxantrone—sarcoma	0.105	0.118	CbGbCtD
Methimazole—CYP1A2—Dacarbazine—sarcoma	0.0786	0.0878	CbGbCtD
Methimazole—CYP3A4—Thiotepa—sarcoma	0.0743	0.083	CbGbCtD
Methimazole—CYP2E1—Etoposide—sarcoma	0.0665	0.0743	CbGbCtD
Methimazole—CYP2B6—Doxorubicin—sarcoma	0.0448	0.05	CbGbCtD
Methimazole—CYP1A2—Etoposide—sarcoma	0.0385	0.043	CbGbCtD
Methimazole—CYP3A4—Mitoxantrone—sarcoma	0.032	0.0357	CbGbCtD
Methimazole—CYP3A4—Vincristine—sarcoma	0.022	0.0246	CbGbCtD
Methimazole—CYP2D6—Doxorubicin—sarcoma	0.0216	0.0241	CbGbCtD
Methimazole—CYP3A4—Etoposide—sarcoma	0.0202	0.0225	CbGbCtD
Methimazole—CYP3A4—Doxorubicin—sarcoma	0.0137	0.0153	CbGbCtD
Methimazole—Pigmentation disorder—Thiotepa—sarcoma	0.00697	0.0668	CcSEcCtD
Methimazole—Pigmentation disorder—Etoposide—sarcoma	0.00501	0.048	CcSEcCtD
Methimazole—Pigmentation disorder—Epirubicin—sarcoma	0.00281	0.0269	CcSEcCtD
Methimazole—Neuritis—Vincristine—sarcoma	0.00276	0.0265	CcSEcCtD
Methimazole—Pigmentation disorder—Doxorubicin—sarcoma	0.0026	0.0249	CcSEcCtD
Methimazole—Aplastic anaemia—Dactinomycin—sarcoma	0.00217	0.0208	CcSEcCtD
Methimazole—Jaundice—Thiotepa—sarcoma	0.00127	0.0122	CcSEcCtD
Methimazole—Neuritis—Epirubicin—sarcoma	0.00126	0.012	CcSEcCtD
Methimazole—Agranulocytosis—Thiotepa—sarcoma	0.00121	0.0116	CcSEcCtD
Methimazole—Agranulocytosis—Dactinomycin—sarcoma	0.00121	0.0116	CcSEcCtD
Methimazole—Neuritis—Doxorubicin—sarcoma	0.00116	0.0111	CcSEcCtD
Methimazole—Hepatitis—Dactinomycin—sarcoma	0.00116	0.0111	CcSEcCtD
Methimazole—Ageusia—Epirubicin—sarcoma	0.00116	0.0111	CcSEcCtD
Methimazole—Neuropathy peripheral—Vincristine—sarcoma	0.00113	0.0108	CcSEcCtD
Methimazole—Drowsiness—Mitoxantrone—sarcoma	0.00112	0.0108	CcSEcCtD
Methimazole—Jaundice—Mitoxantrone—sarcoma	0.0011	0.0105	CcSEcCtD
Methimazole—Ageusia—Doxorubicin—sarcoma	0.00107	0.0103	CcSEcCtD
Methimazole—Agranulocytosis—Mitoxantrone—sarcoma	0.00105	0.0101	CcSEcCtD
Methimazole—Alopecia—Thiotepa—sarcoma	0.00103	0.0099	CcSEcCtD
Methimazole—Alopecia—Dactinomycin—sarcoma	0.00102	0.00982	CcSEcCtD
Methimazole—Hepatitis—Mitoxantrone—sarcoma	0.00101	0.00967	CcSEcCtD
Methimazole—Neuropathy peripheral—Etoposide—sarcoma	0.000917	0.00879	CcSEcCtD
Methimazole—Alopecia—Vincristine—sarcoma	0.000916	0.00878	CcSEcCtD
Methimazole—Jaundice—Etoposide—sarcoma	0.000911	0.00874	CcSEcCtD
Methimazole—Leukopenia—Thiotepa—sarcoma	0.000911	0.00873	CcSEcCtD
Methimazole—Leukopenia—Dactinomycin—sarcoma	0.000904	0.00866	CcSEcCtD
Methimazole—Alopecia—Mitoxantrone—sarcoma	0.000892	0.00855	CcSEcCtD
Methimazole—Aplastic anaemia—Epirubicin—sarcoma	0.00088	0.00843	CcSEcCtD
Methimazole—Agranulocytosis—Etoposide—sarcoma	0.000873	0.00836	CcSEcCtD
Methimazole—Arthralgia—Thiotepa—sarcoma	0.000866	0.0083	CcSEcCtD
Methimazole—Myalgia—Thiotepa—sarcoma	0.000866	0.0083	CcSEcCtD
Methimazole—Myalgia—Dactinomycin—sarcoma	0.00086	0.00824	CcSEcCtD
Methimazole—Oedema—Dactinomycin—sarcoma	0.000824	0.0079	CcSEcCtD
Methimazole—Aplastic anaemia—Doxorubicin—sarcoma	0.000814	0.0078	CcSEcCtD
Methimazole—Thrombocytopenia—Thiotepa—sarcoma	0.000813	0.00779	CcSEcCtD
Methimazole—Vertigo—Vincristine—sarcoma	0.00081	0.00777	CcSEcCtD
Methimazole—Leukopenia—Vincristine—sarcoma	0.000807	0.00774	CcSEcCtD
Methimazole—Thrombocytopenia—Dactinomycin—sarcoma	0.000807	0.00773	CcSEcCtD
Methimazole—Lymphadenopathy—Epirubicin—sarcoma	0.000797	0.00764	CcSEcCtD
Methimazole—Leukopenia—Mitoxantrone—sarcoma	0.000786	0.00754	CcSEcCtD
Methimazole—Myalgia—Vincristine—sarcoma	0.000768	0.00736	CcSEcCtD
Methimazole—Musculoskeletal discomfort—Thiotepa—sarcoma	0.000756	0.00725	CcSEcCtD
Methimazole—Musculoskeletal discomfort—Dactinomycin—sarcoma	0.000751	0.0072	CcSEcCtD
Methimazole—Arthralgia—Mitoxantrone—sarcoma	0.000748	0.00717	CcSEcCtD
Methimazole—Myalgia—Mitoxantrone—sarcoma	0.000748	0.00717	CcSEcCtD
Methimazole—Paraesthesia—Thiotepa—sarcoma	0.000746	0.00715	CcSEcCtD
Methimazole—Alopecia—Etoposide—sarcoma	0.000742	0.00711	CcSEcCtD
Methimazole—Somnolence—Thiotepa—sarcoma	0.000738	0.00708	CcSEcCtD
Methimazole—Lymphadenopathy—Doxorubicin—sarcoma	0.000738	0.00707	CcSEcCtD
Methimazole—Oedema—Vincristine—sarcoma	0.000736	0.00706	CcSEcCtD
Methimazole—Dyspepsia—Thiotepa—sarcoma	0.000731	0.00701	CcSEcCtD
Methimazole—Thrombocytopenia—Vincristine—sarcoma	0.000721	0.00691	CcSEcCtD
Methimazole—Oedema—Mitoxantrone—sarcoma	0.000717	0.00687	CcSEcCtD
Methimazole—Thrombocytopenia—Mitoxantrone—sarcoma	0.000702	0.00673	CcSEcCtD
Methimazole—Musculoskeletal discomfort—Vincristine—sarcoma	0.000671	0.00643	CcSEcCtD
Methimazole—Paraesthesia—Vincristine—sarcoma	0.000661	0.00634	CcSEcCtD
Methimazole—Urticaria—Thiotepa—sarcoma	0.00066	0.00632	CcSEcCtD
Methimazole—Vertigo—Etoposide—sarcoma	0.000657	0.00629	CcSEcCtD
Methimazole—Body temperature increased—Thiotepa—sarcoma	0.000656	0.00629	CcSEcCtD
Methimazole—Leukopenia—Etoposide—sarcoma	0.000654	0.00627	CcSEcCtD
Methimazole—Musculoskeletal discomfort—Mitoxantrone—sarcoma	0.000653	0.00626	CcSEcCtD
Methimazole—Body temperature increased—Dactinomycin—sarcoma	0.000651	0.00624	CcSEcCtD
Methimazole—Paraesthesia—Mitoxantrone—sarcoma	0.000644	0.00617	CcSEcCtD
Methimazole—Somnolence—Mitoxantrone—sarcoma	0.000637	0.00611	CcSEcCtD
Methimazole—Dyspepsia—Mitoxantrone—sarcoma	0.000631	0.00605	CcSEcCtD
Methimazole—Pruritus—Thiotepa—sarcoma	0.000587	0.00563	CcSEcCtD
Methimazole—Thrombocytopenia—Etoposide—sarcoma	0.000584	0.0056	CcSEcCtD
Methimazole—Body temperature increased—Vincristine—sarcoma	0.000582	0.00558	CcSEcCtD
Methimazole—Urticaria—Mitoxantrone—sarcoma	0.00057	0.00546	CcSEcCtD
Methimazole—Body temperature increased—Mitoxantrone—sarcoma	0.000567	0.00543	CcSEcCtD
Methimazole—Paraesthesia—Etoposide—sarcoma	0.000536	0.00513	CcSEcCtD
Methimazole—Somnolence—Etoposide—sarcoma	0.00053	0.00508	CcSEcCtD
Methimazole—Vomiting—Thiotepa—sarcoma	0.000528	0.00506	CcSEcCtD
Methimazole—Drowsiness—Epirubicin—sarcoma	0.000524	0.00502	CcSEcCtD
Methimazole—Vomiting—Dactinomycin—sarcoma	0.000524	0.00502	CcSEcCtD
Methimazole—Rash—Thiotepa—sarcoma	0.000523	0.00502	CcSEcCtD
Methimazole—Dermatitis—Thiotepa—sarcoma	0.000523	0.00501	CcSEcCtD
Methimazole—Headache—Thiotepa—sarcoma	0.00052	0.00499	CcSEcCtD
Methimazole—Rash—Dactinomycin—sarcoma	0.00052	0.00498	CcSEcCtD
Methimazole—Neuropathy peripheral—Epirubicin—sarcoma	0.000514	0.00493	CcSEcCtD
Methimazole—Jaundice—Epirubicin—sarcoma	0.000511	0.0049	CcSEcCtD
Methimazole—Nausea—Thiotepa—sarcoma	0.000493	0.00473	CcSEcCtD
Methimazole—Nausea—Dactinomycin—sarcoma	0.000489	0.00469	CcSEcCtD
Methimazole—Agranulocytosis—Epirubicin—sarcoma	0.000489	0.00469	CcSEcCtD
Methimazole—Drowsiness—Doxorubicin—sarcoma	0.000485	0.00465	CcSEcCtD
Methimazole—Neuropathy peripheral—Doxorubicin—sarcoma	0.000475	0.00456	CcSEcCtD
Methimazole—Urticaria—Etoposide—sarcoma	0.000474	0.00454	CcSEcCtD
Methimazole—Jaundice—Doxorubicin—sarcoma	0.000473	0.00453	CcSEcCtD
Methimazole—Body temperature increased—Etoposide—sarcoma	0.000471	0.00452	CcSEcCtD
Methimazole—Hepatitis—Epirubicin—sarcoma	0.000471	0.00451	CcSEcCtD
Methimazole—Vomiting—Vincristine—sarcoma	0.000468	0.00449	CcSEcCtD
Methimazole—Rash—Vincristine—sarcoma	0.000464	0.00445	CcSEcCtD
Methimazole—Dermatitis—Vincristine—sarcoma	0.000464	0.00445	CcSEcCtD
Methimazole—Headache—Vincristine—sarcoma	0.000461	0.00442	CcSEcCtD
Methimazole—Vomiting—Mitoxantrone—sarcoma	0.000456	0.00437	CcSEcCtD
Methimazole—Agranulocytosis—Doxorubicin—sarcoma	0.000453	0.00434	CcSEcCtD
Methimazole—Rash—Mitoxantrone—sarcoma	0.000452	0.00433	CcSEcCtD
Methimazole—Dermatitis—Mitoxantrone—sarcoma	0.000452	0.00433	CcSEcCtD
Methimazole—Headache—Mitoxantrone—sarcoma	0.000449	0.00431	CcSEcCtD
Methimazole—Nausea—Vincristine—sarcoma	0.000437	0.00419	CcSEcCtD
Methimazole—Hepatitis—Doxorubicin—sarcoma	0.000435	0.00417	CcSEcCtD
Methimazole—Nausea—Mitoxantrone—sarcoma	0.000426	0.00408	CcSEcCtD
Methimazole—Pruritus—Etoposide—sarcoma	0.000422	0.00404	CcSEcCtD
Methimazole—Alopecia—Epirubicin—sarcoma	0.000416	0.00399	CcSEcCtD
Methimazole—Alopecia—Doxorubicin—sarcoma	0.000385	0.00369	CcSEcCtD
Methimazole—Vomiting—Etoposide—sarcoma	0.000379	0.00363	CcSEcCtD
Methimazole—Rash—Etoposide—sarcoma	0.000376	0.0036	CcSEcCtD
Methimazole—Dermatitis—Etoposide—sarcoma	0.000376	0.0036	CcSEcCtD
Methimazole—Headache—Etoposide—sarcoma	0.000374	0.00358	CcSEcCtD
Methimazole—Vertigo—Epirubicin—sarcoma	0.000368	0.00353	CcSEcCtD
Methimazole—Leukopenia—Epirubicin—sarcoma	0.000367	0.00351	CcSEcCtD
Methimazole—Nausea—Etoposide—sarcoma	0.000354	0.0034	CcSEcCtD
Methimazole—Myalgia—Epirubicin—sarcoma	0.000349	0.00334	CcSEcCtD
Methimazole—Arthralgia—Epirubicin—sarcoma	0.000349	0.00334	CcSEcCtD
Methimazole—Vertigo—Doxorubicin—sarcoma	0.000341	0.00326	CcSEcCtD
Methimazole—Leukopenia—Doxorubicin—sarcoma	0.000339	0.00325	CcSEcCtD
Methimazole—Oedema—Epirubicin—sarcoma	0.000334	0.0032	CcSEcCtD
Methimazole—Thrombocytopenia—Epirubicin—sarcoma	0.000327	0.00314	CcSEcCtD
Methimazole—Myalgia—Doxorubicin—sarcoma	0.000323	0.00309	CcSEcCtD
Methimazole—Arthralgia—Doxorubicin—sarcoma	0.000323	0.00309	CcSEcCtD
Methimazole—Oedema—Doxorubicin—sarcoma	0.000309	0.00297	CcSEcCtD
Methimazole—Musculoskeletal discomfort—Epirubicin—sarcoma	0.000305	0.00292	CcSEcCtD
Methimazole—Thrombocytopenia—Doxorubicin—sarcoma	0.000303	0.0029	CcSEcCtD
Methimazole—Paraesthesia—Epirubicin—sarcoma	0.0003	0.00288	CcSEcCtD
Methimazole—Somnolence—Epirubicin—sarcoma	0.000297	0.00285	CcSEcCtD
Methimazole—Dyspepsia—Epirubicin—sarcoma	0.000294	0.00282	CcSEcCtD
Methimazole—Musculoskeletal discomfort—Doxorubicin—sarcoma	0.000282	0.0027	CcSEcCtD
Methimazole—Paraesthesia—Doxorubicin—sarcoma	0.000278	0.00266	CcSEcCtD
Methimazole—Somnolence—Doxorubicin—sarcoma	0.000275	0.00264	CcSEcCtD
Methimazole—Dyspepsia—Doxorubicin—sarcoma	0.000272	0.00261	CcSEcCtD
Methimazole—Urticaria—Epirubicin—sarcoma	0.000266	0.00255	CcSEcCtD
Methimazole—Body temperature increased—Epirubicin—sarcoma	0.000264	0.00253	CcSEcCtD
Methimazole—Urticaria—Doxorubicin—sarcoma	0.000246	0.00236	CcSEcCtD
Methimazole—Body temperature increased—Doxorubicin—sarcoma	0.000245	0.00234	CcSEcCtD
Methimazole—Pruritus—Epirubicin—sarcoma	0.000237	0.00227	CcSEcCtD
Methimazole—Pruritus—Doxorubicin—sarcoma	0.000219	0.0021	CcSEcCtD
Methimazole—Vomiting—Epirubicin—sarcoma	0.000213	0.00204	CcSEcCtD
Methimazole—Rash—Epirubicin—sarcoma	0.000211	0.00202	CcSEcCtD
Methimazole—Dermatitis—Epirubicin—sarcoma	0.000211	0.00202	CcSEcCtD
Methimazole—Headache—Epirubicin—sarcoma	0.000209	0.00201	CcSEcCtD
Methimazole—Nausea—Epirubicin—sarcoma	0.000199	0.0019	CcSEcCtD
Methimazole—Vomiting—Doxorubicin—sarcoma	0.000197	0.00189	CcSEcCtD
Methimazole—Rash—Doxorubicin—sarcoma	0.000195	0.00187	CcSEcCtD
Methimazole—Dermatitis—Doxorubicin—sarcoma	0.000195	0.00187	CcSEcCtD
Methimazole—Headache—Doxorubicin—sarcoma	0.000194	0.00186	CcSEcCtD
Methimazole—Nausea—Doxorubicin—sarcoma	0.000184	0.00176	CcSEcCtD
